FTC sues ticket reseller for evading Taylor Swift’s Eras tour ticket limits - CNN
Yesterday • Google News
Erasca Inc (ERAS)
US$ 00%
Price Chart
Key Statistics
Market Cap
$ 434.02M
P/E Ratio
0.00
Revenue (TTM)
$ 0
Volume
0
52W High
$ 3.31
52W Low
$ 1.01
Dividend Yield
0.00%
Beta
1.07
Technicals
50-Day MA
1.4889
200-Day MA
1.7996
52 Week High
3.305
52 Week Low
1.01
About ERAS
Erasca, Inc., a clinical-stage precision oncology company, focuses on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers.
Employees
103
Headquarters
San Diego, CA
CEO
Dr. Jonathan E. Lim M.D.